| An integrated computational and experimental study uncovers FUT 9 as a metabolic driver of colorectal cancer N Auslander, CE Cunningham, BM Toosi, EJ McEwen, K Yizhak, ... Molecular Systems Biology 13 (12), 956, 2017 | 48 | 2017 |
| Therapeutic relevance of the protein phosphatase 2A in cancer CE Cunningham, S Li, FS Vizeacoumar, KK Bhanumathy, JS Lee, ... Oncotarget 7 (38), 61544, 2016 | 32 | 2016 |
| The CINs of polo-like kinase 1 in cancer CE Cunningham, MJ MacAuley, FS Vizeacoumar, O Abuhussein, ... Cancers 12 (10), 2953, 2020 | 22 | 2020 |
| Targeting the CINful genome: Strategies to overcome tumor heterogeneity CE Cunningham, MJ MacAuley, G Yadav, FS Vizeacoumar, A Freywald, ... Progress in Biophysics and Molecular Biology 147, 77-91, 2019 | 22 | 2019 |
| Expression-based analyses indicate a central role for hypoxia in driving tumor plasticity through microenvironment remodeling and chromosomal instability A Jing, FS Vizeacoumar, S Parameswaran, B Haave, CE Cunningham, ... NPJ systems biology and applications 4 (1), 38, 2018 | 11 | 2018 |
| Molecular characterization of an MLL1 fusion and its role in chromosomal instability S Parameswaran, FS Vizeacoumar, K Kalyanasundaram Bhanumathy, ... Molecular Oncology 13 (2), 422-440, 2019 | 5 | 2019 |
| Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality CE Cunningham, FS Vizeacoumar, Y Zhang, L Kyrylenko, P Gao, ... bioRxiv, 2024.07. 18.603978, 2024 | | 2024 |
| SYNTHETIC DOSAGE LETHAL INTERACTIONS OF POLO-LIKE KINASE 1 AND THEIR APPLICATION IN CANCER THERAPEUTICS CE Cunningham University of Saskatchewan, 2020 | | 2020 |
Franco VizeacoumarAssociate Professor, University of Saskatchewan, Saskatchewan Cancer AgencyEmail verificata su usask.ca